Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN

Author:

Yu Jingyou1ORCID,Thomas Paul V.23ORCID,McMahan Katherine1ORCID,Jacob-Dolan Catherine145ORCID,Liu Jinyan1ORCID,He Xuan1ORCID,Hope David1ORCID,Martinez Elizabeth J.23ORCID,Chen Wei-Hung23,Sciacca Michaela1,Hachmann Nicole P.1ORCID,Lifton Michelle1ORCID,Miller Jessica1ORCID,Powers Olivia C.1,Hall Kevin1,Wu Cindy1ORCID,Barrett Julia1ORCID,Swafford Isabella23ORCID,Currier Jeffrey R.23ORCID,King Jocelyn6ORCID,Corbitt Courtney23,Chang William C.2ORCID,Golub Emily23ORCID,Rees Phyllis A.23ORCID,Peterson Caroline E.23ORCID,Hajduczki Agnes23,Hussin Elizabeth37,Lange Camille37ORCID,Gong Hua37,Matyas Gary R.7ORCID,Rao Mangala7ORCID,Paquin-Proulx Dominic23ORCID,Gromowski Gregory D.6ORCID,Lewis Mark G.8ORCID,Andersen Hanne8ORCID,Davis-Gardner Meredith9ORCID,Suthar Mehul S.9ORCID,Michael Nelson L.10ORCID,Bolton Diane L.23ORCID,Joyce M. Gordon23ORCID,Modjarrad Kayvon2ORCID,Barouch Dan H.145ORCID

Affiliation:

1. Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

2. Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD 20910, USA.

3. Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817, USA.

4. Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02215, USA.

5. Harvard Medical School, Boston, MA 02215, USA.

6. Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.

7. U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.

8. Bioqual, Rockville, MD 20852, USA.

9. Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA.

10. Center for Infectious Diseases Research, Walter Reed Army Institute of Research (WRAIR), Silver Spring, MD 20910, USA.

Abstract

Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and waning immunity call for next-generation vaccine strategies. Here, we assessed the immunogenicity and protective efficacy of two SARS-CoV-2 vaccines targeting the WA1/2020 spike protein, Ad26.COV2.S (Ad26) and Spike ferritin Nanoparticle (SpFN), in nonhuman primates, delivered as either a homologous (SpFN/SpFN and Ad26/Ad26) or heterologous (Ad26/SpFN) prime-boost regimen. The Ad26/SpFN regimen elicited the highest CD4 T cell and memory B cell responses, the SpFN/SpFN regimen generated the highest binding and neutralizing antibody responses, and the Ad26/Ad26 regimen generated the most robust CD8 T cell responses. Despite these differences, protective efficacy against SARS-CoV-2 Omicron BA.1 challenge was similar for all three regimens. After challenge, all vaccinated monkeys showed significantly reduced peak and day 4 viral loads in both bronchoalveolar lavage and nasal swabs as compared with sham animals. The efficacy conferred by these three immunologically distinct vaccine regimens suggests that both humoral and cellular immunity contribute to protection against SARS-CoV-2 Omicron challenge.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3